Literature DB >> 4187843

Intrathecal methotrexate.

K D Bagshawe, I T Magrath, P R Golding.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4187843     DOI： 10.1016/s0140-6736(69)90796-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

2.  Encephalopathy in acute leukaemia associated with methotrexate therapy.

Authors:  H E Kay; P J Knapton; J P O'Sullivan; D G Wells; R F Harris; E M Innes; J Stuart; F C Schwartz; E N Thompson
Journal:  Arch Dis Child       Date:  1972-06       Impact factor: 3.791

3.  Necrotizing myelopathy associated with acute lymphoblastic leukemia. Case report and review of literature.

Authors:  W Grisold; D Lutz; D Wolf
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

4.  Calcified cerebral necrosis following ALL therapy.

Authors:  K M Müller; R Menne; K D Bachmann; H Gröbe
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

5.  Acute reversible neurological deficit following intrathecal chemotherapy.

Authors:  H Dunkelman; H M Earl; C Twelves
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.